Unnamed stage
~$2.3m
Promethean BioPharma raises $2.3M to bring CBD pain tablet to pharmacy shelves
Sydney biotech Promethean BioPharma has launched an OnMarket crowdfunding round to fund manufacturing, trials and its push for non-prescription status of its CBD pain tablet in Australia.